Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology

Guan-Hua Su; Yi Xiao; Yi-Zhou Jiang; Zhi-Ming Shao

doi:10.1016/j.xcrm.2022.100808

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology

Cell Rep Med. 2022 Dec 20;3(12):100808. doi: 10.1016/j.xcrm.2022.100808.

Authors

Guan-Hua Su¹, Yi Xiao¹, Yi-Zhou Jiang¹, Zhi-Ming Shao²

Affiliations

¹ Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
² Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: zhimingshao@fudan.edu.cn.

Abstract

In this Backstory, we illustrate how a recent work from our multidisciplinary collaborative group identifies molecular subtypes of triple-negative breast cancer with a noninvasive radiomic pipeline. These findings appeared in the July 2022 issue of Cell Reports Medicine (https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(22)00230-0).

MeSH terms

Humans
Medicine*
Triple Negative Breast Neoplasms* / diagnostic imaging
Triple Negative Breast Neoplasms* / genetics